Writing in Molecular Therapy Nucleic Acids, researchers hypothesized that using poly(A) tail mimetics to enhance mRNA expression from haploinsufficiency-associated genes could be a disease-modifying ...

Combining mRNA with a specialised lipid nanoparticle could reach areas of the lungs previously inaccessible to conventional ...

In the default model, the graph representing each individual enhancer can be arbitrarily complicated. To show how the ABC Score formula can arise from the default model, we need to impose the further ...

Ethris has partnered Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

Recently, the research teams led by Professors Yu Tao and Feng Yugong from The Affiliated Hospital of Qingdao University ...

丁苯酞作为一种神经保护药物，在治疗缺血性脑卒中方面展现出了潜力，它可以通过扩张脑血管、改善脑血流、减轻氧化应激等多种方式发挥作用。然而，其具体的作用机制却像一团迷雾，并不完全清楚。与此同时，信使核糖核酸（mRNA，作为蛋白质合成的模板，在生物过程中起着核心作用）和长链非编码核糖核酸（lncRNA，虽不编码蛋白质，但在基因表达调控中意义重大）在脑血管疾病的发生发展中扮演着重要角色，二者的共表达网络能 ...

Breast Cancer Animal Studies Show Unprecedented Anti-Cancer Efficacy of 100% Tumor Growth Inhibition HONG KONG, CHINA / ACCESS Newswire / April 11, 2025 / CK Life Sciences Int'l., (Holdings) Inc. ("CK ...

Esophageal basaloid squamous cell carcinoma (EBSCC) is a rare type of esophageal squamous cell cancer (ESCC) characterized by basaloid features and considered to be more aggressive than ESCC. RNA ...